 |  |  |
Illumina, one of the largest DNA sequencing companies, early this year announced the formation of a startup known as Grail, which plans to develop blood tests that can potentially detect many cancers for the cost of $1000 or less. The company said at the time that it hopes to make the technology available by 2019. It could be offered through a personal physician's office, or possibly through a network of testing centers.
Discover how medtech is fighting Zika>>
[Image courtesy of Grail]
0 comments
Hide comments
